Rickettsia felis in the United Kingdom by Kenny, Martin J. et al.
Emerging Infectious Diseases • Vol. 9, No. 8, August 2003 1023
LETTERS
2. Pournaras S, Tsakris A, Maniati M,
Tzouvelekis LS, Maniatis AN. Novel vari-
ant (bla(VIM-4)) of the metallo-β-lacta-
mase gene bla(VIM-1) in a clinical strain of
Pseudomonas aeruginosa. Antimicrob
Agents Chemother 2002;46:4026–8.
3. Toleman MA, Rolston K, Jones RN, Walsh
TR. Molecular characterization of VIM-4, a
novel metallo-β-lactamase isolated from
Texas: report from the CANCER surveil-
lance program. In: 42nd ICAAC Abstracts,
San Diego, CA, 2002 Sep 27–30;
Washington: American Society for
Microbiology; 2002.
4. Docquier JD, Lamotte-Brasseur J, Galleni
M, Amicosante G, Frere JM, Rossolini GM.
On functional and structural heterogeneity
of VIM-type metallo-β-lactamases. J
Antimicrob Chemother 2003;51:257–66.
5. Tambic Andrasevic A, Tambic T, Kalenic S,
Jankovic V, Working Group of the Croatian
Committee for Antibiotic Resistance
Surveillance. Surveillance for antimicrobial
resistance in Croatia. Emerg Infect Dis
2002;8:14–8.
6. Cornaglia G, Mazzariol A, Lauretti L,
Rossolini GM, Fontana R. Hospital out-
break of carbapenem-resistant
Pseudomonas aeruginosa producing VIM-
1, a novel transferable metallo-β-lactamase.
Clin Infect Dis 2000;31:1119–25.
7. Lauretti L, Riccio L, Mazzariol G,
Cornaglia G, Amicosante G, Fontana R, et
al. Cloning and characterization of blaVIM, a
new integron-borne metallo-β-lactamase
gene from Pseudomonas aeruginosa clini-
cal isolate. Antimicrob Agents Chemother
1999;43:1584–90.
8. Riccio ML, Franceschini N, Boschi L,
Caravelli B, Cornaglia G, Fontana R, et al.
Characterization of the metallo-β-lactamase
determinant of Acinetobacter baumannii
AC-54/97 reveals the existence of bla(IMP)
allelic variants carried by gene cassettes of
different phylogeny. Antimicrob Agents
Chemother 2000;44:1229–35.
9. Riccio M, Pallecchi L, Fontana R,
Rossolini GM. In 70 of plasmid pAX22, a
blaVIM-1-containing integron carrying a new
aminoglycoside phosphotransferase gene
cassette. Antimicrob Agents Chemother
2001;45:1249–53.
10. Sambrook J, Fritsch EF, Maniatis T.
Molecular cloning: a laboratory manual.
Cold Spring Harbor (NY): Cold Spring
Harbor Laboratory Press; 1989.
Address for correspondence: Gian Maria
Rossolini, Dipartimento di Biologia
Molecolare, Sez. Microbiologia, Università di
Siena, Policlinico Le Scotte, 53100, Siena,
Italy; fax: 39 0577 233325; email:
rossolini@unisi.it
Rickettsia felis in
the United
Kingdom
To the Editor: Rickettsia felis is a
bacterium transmitted by the cat flea
(Ctenocephalides felis), which also
acts as a reservoir by means of transo-
varial transmission (1–3). The distri-
bution of R. felis is potentially as wide
as that of its insect host, and to date,
its presence has been confirmed in cat
flea populations in North and South
America and southern Europe (4,5).
R. felis was first identified as a human
pathogen in 1994 (6), and cases of
“flea-borne spotted fever,” which
have signs and symptoms of febrile
exanthema, have now been reported
in the United States, Mexico, Brazil,
France, and Germany (7,8). To our
knowledge, reports on the presence of
R. felis, or indeed any other spotted
fever group rickettsia, in the United
Kingdom have not been published.
To determine whether R. felis is
present in the United Kingdom, we
surveyed cat fleas collected from dogs
and cats seen at veterinary practices in
southern England and Northern
Ireland. Atotal of 31 dogs and 79 cats
from veterinary practices in Bristol,
Dorset, London, Devon, Gloucester-
shire, Hampshire, and Antrim were
included in our study. Fleas were col-
lected by combing these animals for
10 minutes. All fleas from each ani-
mal were pooled in 70% ethanol. A
total of 316 Ct. felis (Bouché, 1835),
identified by using accepted morpho-
logic criteria, were obtained, with
each animal yielding one to five fleas.
DNA was extracted from each of the
110 flea pools by using a standard sil-
ica cartridge method (QiaAmp DNA
mini kit, QIAGEN Ltd., Crawley,
West Sussex, U.K.) using the manu-
facturer’s instructions for tissue DNA
extraction. The presence of rickettsial
DNA was determined by using the
polymerase chain reaction (PCR) with
oligonucleotide primers that target
rickettesial  ompB  (5) or gltA (2)
genes. Positive control material was
cultured R. felis. Rigorous controls to
limit contamination were carried out,
including the use of separate, dedicat-
ed rooms for DNA extraction, PCR
setup, and gel analysis. Amplification
products obtained from ompB  and
gltA PCRs were analyzed by using
DNAsequencing. Sequences obtained
were edited by using BioEdit (avail-
able from: URL: http://www.mbio.
mncsu.edu/BioEdit/bioedit.html).
Similarity to published sequences was
determined with the BLAST program
(available from: URL: http://www.
ncbi.nlm.nih.gov) hosted by the
National Centre for Biotechnology
Information.
Eighteen flea DNA pools were
positive for spotted fever group rick-
ettsia. All 18 yielded PCR products
with both ompB  and  gltA-targeting
PCRs. The ompB  and  gltA DNA
sequences of all PCR products were
100% identical to those published for
R. felis, thereby providing evidence
for the presence of R. felis in fleas col-
lected from >16% of the animals sur-
veyed. PCR-positive fleas were col-
lected from 4 dogs and 14 cats from
Bristol, Hampshire, Dorset, and
Northern Ireland. Taking into account
the number of fleas in each pool, we
estimate that 6% to 12% of the fleas
collected were infected with R. felis.
This study represents the first
description of a spotted fever group
rickettsia endemic to the United
Kingdom. The species detected, R.
felis, has clear public health implica-
tions. The bacterium appears to be
widely distributed within the country,
infecting a geographically dispersed
population of Ct. felis. Up to 12% of
Ct. felis may be infected with R. felis,
a flea that is by far the most common
species of ectoparasite encountered
on cats and dogs in the U.K. main-1024 Emerging Infectious Diseases • Vol. 9, No. 8, August 2003
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land. Furthermore, Ct. felis often
feeds on humans. 
Clinicians encountering patients
with fever or rash (or both) and a his-
tory of cat contact or flea bites should
consider a diagnosis of R. felis.
Laboratory confirmation of infection
is not easy, but in vitro culture of R.
felis, and hence material for a sero-
logic assay for the diagnosis of
human R. felis infections, has recent-
ly been described, and serology
appears to be an accurate indicator of
exposure (9). As with other spotted
fever group rickettsial infections,
molecular diagnostics may provide a
useful alternative approach to detect-
ing and identifying R. felis in infected
tissues. In culture, R. felis has been
shown to be resistant to erythromycin
(unlike other rickettsia), gentamicin,
amoxicillin, and trimethoprim-sul-
famethoxazole. Thus, infection with
this bacterium should be considered
in cases of antibiotic-insensitive fever
with a rash, especially in young, old,
and immunosuppressed persons. The
organism is sensitive to doxycycline,
rifampicin, thiamphenicol, and fluo-
roquinolones (10)
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Community
Transmission of
Extended-Spectrum
β-Lactamase 
To the Editor: The spread of mul-
tiresistant gram-negative bacteria in
the general population is a problem of
paramount importance, but the
responsible mechanisms are poorly
understood. Several studies have
focused on β-lactam resistance in
Enterobacteriaceae isolated from
stools in healthy people, but they did
not specifically investigate the
extended-spectrum  β-lactamases
(ESBL). Furthermore, none of these
studies detected ESBL in the evaluat-
ed population (1,2). We performed
three survey studies to determine the
incidence of Enterobacteriaceae
strains producing ESBLs in the stools
of outpatients attending our hospital.
The first study was performed during
a 4-month period (February–May
2001), the second during a 3 month-
period (April–June 2002), and the
third during 1 month (October 2002). 
Stool samples were spread onto
plates of MacConkey agar containing
2 mg/L of cefotaxime. A colony of
each distinct morphotype was ana-
lyzed further. Species were identified
according to conventional methods
(3). The susceptibility to β-lactam
antibiotics was determined by the
disk-diffusion test, following recom-
mendations of the National
Committee for Clinical Laboratory
Standards (4,5). The interpretative
reading of the antibiogram was per-
formed according to standard guide-
lines (4–6). The MICs of cefotaxime
and ceftazidime, with and without
clavulanic acid, were later determined
by Etest (AB Biodisk, Solna,
Sweden). Strains producing ESBL
were defined as strains showing syn-
ergism between amoxicillin-clavulan-
ic acid and cefotaxime, ceftazidime,
cefepime, or aztreonam (4,5).
All strains suspected of carrying a
resistance pattern compatible with